The controversial treatment is an antibiotic treatment, more specifically minocycline (Minocin) or the tetracycline group of antibiotics, and is explained amidst a swirl of information which includes:
- history of antibiotic treatment
- theories about antibiotic treatment
- clinical trial results
- patient testimonials
Impact From MIRA (Minocycline In Rheumatoid Arthritis) Trial
"The New Arthritis Breakthrough" interprets the information and presents remarkable stories of improvement and remissions, but also reveals why such positive results went ignored for years by the medical establishment.
Much of the book is devoted to the story of Dr. Thomas McPherson Brown, his research related to the antibiotic treatment, and his quest to find acceptance for his research. "The Road Back" which is a book about Brown’s lifetime of research is included as part of "The New Arthritis Breakthrough". Most notably "The New Arthritis Breakthrough" concentrates on the impact of the MIRA trial (Minocycline In Rheumatoid Arthritis). For decades the theory that rheumatoid arthritis was caused by an infectious agent and could be appropriately treated by antibiotics was overlooked. However, since publication of the MIRA trial in 1995, some physicians and patients are reconsidering minocycline as a treatment option.
Even the theory that minocycline works as an antibiotic is such cases is being reassessed and a newer theory that it acts by blocking the enzymes that destroy cartilage inside the joints has developed.
Learn More About The Antibiotic Treatment Option
This book is packed with information about the antibiotic treatment for rheumatoid arthritis and related diseases. It is a must-read for people on the treatment or for those people considering it as a treatment option. A full understanding of the treatment is easily gained by reading this book.
The author, Henry Scammell, is a medical writer and researcher and has been involved in the search for a cure for rheumatoid arthritis and other forms of inflammatory arthritis for more than ten years.